Fig. 4From: Characterization of IL-19, -20, and -24 in acute and chronic kidney diseases reveals a pro-fibrotic role of IL-24The effect of fibrosis related factors on the expression of IL19, IL20, and IL24 in PBMCs. The mRNA expression of IL19, IL20, and IL24 in healthy (a–c) and CKD-derived (d–f) PBMCs after TGF-β1, PDGF-B, H2O2, IL-1β, and LPS treatment was measured by real-time RT-PCR in a comparison with RPLP0 as internal control. Values were expressed as mean ± SD. n = 5–6 in each group; *p < 0.05 vs. control (Mann–Whitney U-test)Back to article page